D-33
NDC 58264-0033, ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, and ZINC, solution, from DNA Labs, Inc..
- Product NDC
- 58264-0033
- Status
- Listed
- Labeler
- DNA Labs, Inc.
- Dosage form
- SOLUTION
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0033 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATROPA BELLADONNA30 [hp_X]/mL
- BUFO BUFO CUTANEOUS GLAND200 [hp_X]/mL
- COPPER12 [hp_X]/mL
- ANEMONE PRATENSIS30 [hp_X]/mL
- SILICON DIOXIDE30 [hp_X]/mL
- ZINC12 [hp_X]/mL
Pharmacologic classes
Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Inhibit Ovum Fertilization [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58264-0033-1 | 58264003301 | 29.57 mL in 1 BOTTLE, GLASS (58264-0033-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58264-0033 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0033 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58264-0033. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.